DSA8 is a type II kinase inhibitor with IRE1 RNase modulating activity. DSA8 can be used for the research of cancer, metabolic disease, suah as diabetes[1].
Molecular Weight:
615.73
CAS Number:
[1157857-37-8]
Formula:
C35H37N9O2
Target:
IRE1
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted